Le Lézard
Classified in: Health
Subjects: SVY, TRI, DIS, SCZ, DEI

Auditory Insight Outlines Best Practices for Hearing Loss Patient's Journey


The firm's consumer-patient journey framework applies across hearing healthcare, from OTC hearing aids to genetic testing

NEW HAVEN, Conn., Aug. 17, 2023 /PRNewswire/ -- Auditory Insight, a leading consultancy for the hearing healthcare industry, analyzes the central role of the consumer-patient journey in creating market development strategies?for interventions from hearing aids to genetic testing?in its Q3 2023 Research Note.  

Download the Research Note: Go-To-Market Strategy in Hearing Healthcare - The Essential Consumer-Patient Journey.

In many hearing healthcare interventions, market development strategies focus on unmet clinician needs. Audiologists decide which hearing aid brands to recommend in their clinic, while neurotologists who perform cochlear implantation recommend genetic testing.

Far too often, the strategy development process in hearing healthcare neglects to analyze the consumer-patient journey.

"We believe that's a mistake," declares Nancy M. Williams, president of Auditory Insight. "The consumerization of healthcare, in which consumers play an active role in managing their care, is an important force. Understanding the consumer-patient journey is more essential for strategy development than ever."

Williams adds that the presence of global brands like Sony, Apple, Intel, and EssilorLuxottica in hearing aids and hearing enhancement will only accelerate the process of consumers driving their treatment.

Auditory Insight has developed a proprietary framework for analyzing the consumer-patient journey in hearing healthcare. The company deployed the framework across multiple sectors of hearing healthcare, including hearing aids, cochlear implants, and genetic testing.

The company's latest research note describes four best practices for assessing the consumer-patient journey:

  1. Conceive of the journey in its totality, from consumer-patients first becoming aware of their hearing loss until they integrate the hearing intervention into their daily lives.
  2. Focus on the consumer-patient's current journey, their actual lived experiences, including their struggles and difficulties, to find opportunities.
  3. Map the consumer journey along various dimensions; Auditory Insight uses multiple dimensions in behavioral, psychological, and structural domains.
  4. Integrate the consumer-patient journey with the experiences of other market stakeholders, like audiologists, ENTs, and genetic counselors.

Williams describes one engagement for a hearing healthcare company interested in increasing the prevalence of genetic testing. Comparing clinicians' and consumer-patients' experiences yielded tremendous insight. "We were stunned to learn that one key aspect of the clinical narrative actually suppressed patient interest in genetic testing. Audiologists and ENTs did not realize that in response to this common narrative, close to half of patients immediately shut down, ignoring recommendations," she explains.

Williams is available to discuss this research and the implications for hearing healthcare companies.

About Auditory Insight

Auditory Insight partners with senior leaders of hearing health device and pharmaceutical companies to develop successful go-to-market strategies.  The firm also advises growth equity and private equity funds on creating portfolio value in hearing healthcare.

SOURCE Auditory Insight LLC


These press releases may also interest you

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: